Pinho Maria João, Gomes Pedro, Serrão Maria Paula, Bonifácio Maria João, Soares-da-Silva Patrício
Institute of Pharmacology and Therapeutics, Faculty of Medicine, Porto, Portugal.
Hypertension. 2003 Oct;42(4):613-8. doi: 10.1161/01.HYP.0000091822.00166.B1. Epub 2003 Sep 15.
Spontaneously hypertensive rats (SHR) might have increased renal production of dopamine. L-3,4-Dihydroxyphenylalanine (L-DOPA) uptake in renal epithelial cells is promoted through the type 2 L-type amino acid transporter (LAT2), and this might rate-limit the synthesis of renal dopamine. The present study evaluated L-DOPA uptake in isolated renal proximal tubules of SHR and normotensive controls (Wistar-Kyoto rats [WKY]). Expression of LAT1 and LAT2 in the renal cortex and intestinal mucosa was also evaluated. Tubular uptake of L-DOPA in WKY and SHR was a saturable process, being greater in the latter than the former at both 4 and 12 weeks of age. cDNA fragments (LAT1, 688 bp; LAT2, 729 bp) labeled with 32P were used as probes for Northern blot analysis. Expression of LAT2 in SHR kidneys was higher than in WKY kidneys. This increase was more marked at 4 than at 12 weeks of age. Intestinal LAT2 expression, however, was identical in SHR and WKY at both 4 and 12 week of age. By Northern blot analysis, the LAT1 transcript was not identified in either the kidney or intestine. Kidney total RNA was then reverse-transcribed and amplified by polymerase chain reaction with specific primers for LAT1. The presence of a fragment of the expected size for LAT1 led to the conclusion that LAT1 mRNA is a rare message in kidney. We conclude that overexpression of LAT2 in the SHR kidney might contribute to the enhanced L-DOPA uptake, which is organ specific and precedes the onset of hypertension.
自发性高血压大鼠(SHR)的肾脏多巴胺生成可能增加。L-3,4-二羟基苯丙氨酸(L-DOPA)通过2型L型氨基酸转运体(LAT2)促进肾上皮细胞摄取,这可能是肾多巴胺合成的限速因素。本研究评估了SHR和正常血压对照(Wistar-Kyoto大鼠[WKY])分离的肾近端小管中L-DOPA的摄取。还评估了LAT1和LAT2在肾皮质和肠黏膜中的表达。WKY和SHR肾小管对L-DOPA的摄取是一个可饱和过程,在4周龄和12周龄时,SHR的摄取均高于WKY。用32P标记的cDNA片段(LAT1,688 bp;LAT2,729 bp)作为探针进行Northern印迹分析。SHR肾脏中LAT2的表达高于WKY肾脏。这种增加在4周龄时比12周龄时更明显。然而,在4周龄和12周龄时,SHR和WKY的肠道LAT2表达相同。通过Northern印迹分析,在肾脏或肠道中均未鉴定出LAT1转录本。然后将肾脏总RNA进行逆转录,并用LAT1的特异性引物通过聚合酶链反应进行扩增。存在预期大小的LAT1片段,得出LAT1 mRNA在肾脏中是稀有信息的结论。我们得出结论,SHR肾脏中LAT2的过表达可能有助于增强L-DOPA的摄取,这是器官特异性的,且在高血压发作之前出现。